Hudson Edge Investment Partners Inc. Sells 25,023 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Hudson Edge Investment Partners Inc. lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 38.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 40,749 shares of the company’s stock after selling 25,023 shares during the quarter. Hudson Edge Investment Partners Inc.’s holdings in Henry Schein were worth $2,820,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. FMR LLC raised its stake in Henry Schein by 7.8% during the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after acquiring an additional 237,888 shares during the period. Southpoint Capital Advisors LP increased its stake in shares of Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares in the last quarter. Nuance Investments LLC raised its position in shares of Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares during the period. Clarkston Capital Partners LLC lifted its stake in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after buying an additional 71,560 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Henry Schein by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock worth $85,662,000 after buying an additional 6,184 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Price Performance

HSIC stock opened at $77.24 on Friday. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The firm has a market capitalization of $9.63 billion, a P/E ratio of 31.79, a price-to-earnings-growth ratio of 2.12 and a beta of 0.91. The company has a fifty day simple moving average of $74.14 and a two-hundred day simple moving average of $72.21. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group lifted their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Barrington Research boosted their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, January 30th. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.